📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Purity of transferred CD8(+) T cells is crucial for safety and efficacy of combinatorial tumor immunotherapy in the absence of SHP-1. (2016)

First Author: Watson HA
Attributed to:  Dissecting the impact of L-selectin on T lymphocyte dependent tumour immunity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/icb.2016.45

PubMed Identifier: 27430370

Publication URI: http://europepmc.org/abstract/MED/27430370

Type: Journal Article/Review

Volume: 94

Parent Publication: Immunology and cell biology

Issue: 8

ISSN: 0818-9641